Encouraging pulmonary outcome for surviving, neurologically intact, extremely premature infants in the postsurfactant era

Chest

Volumn 142, Issue 3, 2012, Pages 725-733

  Kaplan, Eytan ^a   Bar Yishay, Ephraim ^a   Prais, Dario ^b   Klinger, Gil ^a,b   Mei Zahav, Meir ^a,b   Mussaffi, Huda ^a,b   Steuer, Guy ^a   Hananya, Shai ^a   Matyashuk, Yelena ^a   Gabarra, Nassrin ^a   Sirota, Lea ^a,b   Blau, Hannah ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; METHACHOLINE; NITRIC OXIDE; OXYGEN; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY EXERCISE TEST; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; INHALATION TEST; LUNG DIFFUSION; LUNG DIFFUSION CAPACITY; LUNG DYSPLASIA; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; POSTNATAL CARE; PREMATURITY; PRENATAL CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESIDUAL VOLUME; SCHOOL CHILD; SPIROMETRY; SYMPTOM; TOTAL LUNG CAPACITY; WHEEZING;

EID: 84865850286     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1562     Document Type: Article

References (47)

1. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bron chopulmonary dysplasia. N Engl J Med. 1967;276(7):357-368.
2. Northway WH Jr, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med. 1990;323(26):1793-1799.
3. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46(6):641-643.
4. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19):1946-1955. (Pubitemid 350074689)
5. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003;8(1):73-81. (Pubitemid 36356495)
6. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29(7):710-717. (Pubitemid 28322056)
7. Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure Study. Am J Respir Crit Care Med. 2010;182(2):237-245.
8. Welsh L, Kirkby J, Lum S, et al EPICure Study Group. The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax. 2010; 65(2):165-172.
9. Narang I, Rosenthal M, Cremonesini D, Silverman M, Bush A. Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med. 2008;178(1):74-80. (Pubitemid 351919195)
10. Vrijlandt EJ, Gerritsen J, Boezen HM, Grevink RG, Duiverman EJ. Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med. 2006;173(8):890-896.
11. Korhonen P, Laitinen J, Hyödynmaa E, Tammela O. Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era. Acta Paediatr. 2004;93(3):316-321. (Pubitemid 38316552)
12. Doyle LW; Victorian Infant Collaborative Study Group. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992. Pediatr Pulmonol. 2006;41(6):570-576.
13. Baraldi E, Bonetto G, Zacchello F, Filippone M. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med. 2005;171(1):68-72. (Pubitemid 40051697)
14. Broström EB, Thunqvist P, Adenfelt G, Borling E, Katz-Salamon M. Obstructive lung disease in children with mild to severe BPD. Respir Med. 2010;104(3):362-370.
15. Halvorsen T, Skadberg BT, Eide GE, Røksund OD, Carlsen KH, Bakke P. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr. 2004;93(10):1294-1300. (Pubitemid 39273899)
16. Gabriele C, Nieuwhof EM, Van Der Wiel EC, et al. Exhaled nitric oxide differentiates airway diseases in the first two years of life. Pediatr Res. 2006;60(4):461-465. (Pubitemid 44427601)
17. Narang I, Bush A, Rosenthal M. Gas transfer and pulmonary blood flow at rest and during exercise in adults 21 years after preterm birth. Am J Respir Crit Care Med. 2009;180(4):339-345.
18. Kilbride HW, Gelatt MC, Sabath RJ. Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease. J Pediatr. 2003;143(4):488-493. (Pubitemid 37352508)
19. Pianosi PT, Fisk M. Cardiopulmonary exercise performance in prematurely born children. Pediatr Res. 2000;47(5):653- 658.
20. Santuz P, Baraldi E, Zaramella P, Filippone M, Zacchello F. Factors limiting exercise performance in long-term survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med. 1995;152(4 pt 1):1284-1289.
21. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-1729. (Pubitemid 32578778)
22. Ehrenkranz RA, Walsh MC, Vohr BR, et al National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116(6):1353-1360. (Pubitemid 46056482)
23. Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Philadelphia, PA: W. B. Saunders;1971.
24. Weng TR, Levison H. Standards of pulmonary function in children. Am Rev Respir Dis. 1969;99(6):879-894.
25. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930.
26. Miller MR, Crapo R, Hankinson J, et al. ATS/ERS Task Force: Standardisation of lung function testing. Part 1. Eur Respir J. 2005;26(1):153-161.
27. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511-522. (Pubitemid 41264217)
28. Izbicki G, Bar-Yishay E. Methacholine inhalation challenge: a shorter, cheaper and safe approach. Eur Respir J. 2001;17(1):46-51. (Pubitemid 32600555)
29. Crapo RO, Casaburi R, Coates AL, et al American Thoracic Society. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309-329.
30. Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Principles of Exercise Testing and Interpretation. 4th ed. Baltimore, MD: Lippincott Williams and Wilkins; 2005.
31. Cooper DM, Weiler-Ravell D, Whipp BJ, Wasserman K. Aerobic parameters of exercise as a function of body size during growth in children. J Appl Physiol. 1984;56(3):628-634. (Pubitemid 14149470)
32. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211-277.
33. Armstrong N, Welsman JR. Aerobic fitness. In: Armstrong N, van Mechelen W, eds. Paediatric Exercise Science and Medicine. Oxford, England: Oxford University Press; 2000:65-75.
34. Dixon WJ, ed. BMDP Statistical Software. Los Angeles, CA: University of California Press;1993.
35. Kramer MS, Platt RW, Wen SW, et alFetal/Infant Health Study Group of the Canadian Perinatal Surveillance System. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2):E35.
36. Romano-Zelekha O, Graif Y, Garty BZ, Livne I, Green MS, Shohat T. Trends in the prevalence of asthma symptoms and allergic diseases in Israeli adolescents: results from a national survey 2003 and comparison with 1997. J Asthma. 2007;44(5):365-369. (Pubitemid 47026922)
37. Palta M, Sadek-Badawi M, Madden K, Green C. Pulmonary testing using peak flow meters of very low birth weight children born in the perisurfactant era and school controls at age 10 years. Pediatr Pulmonol. 2007;42(9):819-828. (Pubitemid 47580809)
38. Gappa M, Berner MM, Hohenschild S, Dammann CEL, Bartmann P. Pulmonary function at school-age in surfactant-treated preterm infants. Pediatr Pulmonol. 1999;27(3):191- 198.
39. Halvorsen T, Skadberg BT, Eide GE, Røksund O, Aksnes L, Øymar K. Characteristics of asthma and airway hyperresponsiveness after premature birth. Pediatr Allergy Immunol. 2005;16(6):487-494. (Pubitemid 41414990)
40. Siltanen M, Savilahti E, Pohjavuori M, Kajosaari M. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol. 2004;37(1):43-49. (Pubitemid 38030069)
41. Lambert RK, ParéPD. Lung parenchymal shear modulus, airway wall remodeling, and bronchial hyperresponsiveness. J Appl Physiol. 1997;83(1):140-147. (Pubitemid 27304742)
42. Brusasco V, Pellegrino R. Complexity of factors modulating airway narrowing in vivo: relevance to assessment of airway hyperresponsiveness. J Appl Physiol. 2003;95(3):1305-1313.
43. Tiddens HAWM, Hofhuis W, Casotti V, Hop WC, Hulsmann AR, de Jongste JC. Airway dimensions in bronchopulmonary dysplasia:implications for airflow obstruction. Pediatr Pulmonol. 2008;43(12):1206-1213.
44. Fellman V, Hellström-Westas L, Norman M, et al EXPRESS Group. One-year survival of extremely preterm infants after active perinatal care in Sweden. JAMA. 2009;301(21):2225-2233.
45. Berger TM, Bachmann II, Adams M, Schubiger G. Impact of improved survival of very low-birth-weight infants on incidence and severity of bronchopulmonary dysplasia. Biol Neonate. 2004;86(2):124-130. (Pubitemid 39140333)
46. Doyle LW, Anderson PJ. Long term outcome of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009;14(6):391-395.
47. Stoll BJ, Hansen NI, Bell EF, et al Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443-456.